Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Ind-Swift Laboratories Yönetim
Yönetim kriter kontrolleri 2/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Navrattan Munjal
İcra Kurulu Başkanı
₹30.3m
Toplam tazminat
| CEO maaş yüzdesi | 99.9% |
| CEO görev süresi | 29.5yrs |
| CEO sahipliği | 1.6% |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 5.4yrs |
Son yönetim güncellemeleri
Recent updates
Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Stock Rockets 29% But Many Are Still Ignoring The Company
Jul 02
Shareholders In Ind-Swift Laboratories (NSE:INDSWFTLAB) Should Look Beyond Earnings For The Full Story
May 21Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Surges 26% Yet Its Low P/E Is No Reason For Excitement
Apr 13Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly
Dec 28These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Reasonably Well
Jul 22Ind-Swift Laboratories (NSE:INDSWFTLAB) Has A Somewhat Strained Balance Sheet
Jul 12Did Business Growth Power Ind-Swift Laboratories' (NSE:INDSWFTLAB) Share Price Gain of 231%?
Feb 17We're Not So Sure You Should Rely on Ind-Swift Laboratories's (NSE:INDSWFTLAB) Statutory Earnings
Dec 30These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Extensively
Nov 11Is Ind-Swift Laboratories (NSE:INDSWFTLAB) A Risky Investment?
Jun 27CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹4b |
| Mar 31 2024 | ₹30m | ₹30m | ₹4b |
| Dec 31 2023 | n/a | n/a | ₹432m |
| Sep 30 2023 | n/a | n/a | ₹513m |
| Jun 30 2023 | n/a | n/a | ₹450m |
| Mar 31 2023 | ₹36m | ₹36m | ₹476m |
| Dec 31 2022 | n/a | n/a | ₹113m |
| Sep 30 2022 | n/a | n/a | -₹2m |
| Jun 30 2022 | n/a | n/a | -₹11m |
| Mar 31 2022 | ₹36m | ₹36m | -₹21m |
| Dec 31 2021 | n/a | n/a | ₹301m |
| Sep 30 2021 | n/a | n/a | ₹256m |
| Jun 30 2021 | n/a | n/a | ₹111m |
| Mar 31 2021 | ₹33m | ₹33m | -₹31m |
| Dec 31 2020 | n/a | n/a | ₹277m |
| Sep 30 2020 | n/a | n/a | ₹77m |
| Jun 30 2020 | n/a | n/a | -₹111m |
| Mar 31 2020 | ₹30m | ₹30m | -₹212m |
| Dec 31 2019 | n/a | n/a | -₹734m |
| Sep 30 2019 | n/a | n/a | -₹211m |
| Jun 30 2019 | n/a | n/a | -₹35m |
| Mar 31 2019 | ₹18m | ₹18m | ₹289m |
| Mar 31 2018 | ₹18m | ₹18m | ₹220m |
Tazminat ve Piyasa: Navrattan's total compensation ($USD361.57K) is above average for companies of similar size in the Indian market ($USD42.04K).
Tazminat ve Kazançlar: Navrattan's compensation has been consistent with company performance over the past year.
CEO
Navrattan Munjal (72 yo)
29.5yrs
Görev süresi
₹30,308,000
Tazminat
Mr. Navrattan R. Munjal has been a Managing Director of Ind-swift Laboratories Ltd. since March 29, 2001 and serves as its Chairman. He served as President of Indian Drug Manufacturers’ Association until J...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & MD | 29.5yrs | ₹30.31m | 1.56% ₹ 118.4m | |
| Joint MD & Whole Time Director | 21.3yrs | ₹37.88m | 0.69% ₹ 52.3m | |
| Executive Director | 14.6yrs | ₹15.16m | 0.77% ₹ 58.8m | |
| President of Operations & Special Assignments and Executive Director | 4.7yrs | ₹17.92m | 0.011% ₹ 870.0k | |
| Non-Executive Independent Director | 12.1yrs | ₹186.75k | Veri yok | |
| Non-Executive Independent Director | 4.7yrs | ₹123.75k | Veri yok | |
| Non-Executive Independent Woman Director | 5.4yrs | ₹85.50k | Veri yok | |
| Non-Executive Independent Director | 3.3yrs | ₹148.50k | Veri yok | |
| Independent Director | less than a year | Veri yok | Veri yok |
5.4yrs
Ortalama Görev Süresi
68yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: INDSWFTLAB's board of directors are considered experienced (5.4 years average tenure).